Nitric Oxide–cGMP Pathway Modulation in an Experimental Model of Hypoxic Pulmonary Hypertension

Manipulation of nitric oxide (NO) may enable control of progression and treatment of pulmonary hypertension (PH). Several approaches may modulate the NO-cGMP pathway in vivo. Here, we investigate the effectiveness of 3 modulatory sites: (i) the amount of l-arginine; (ii) the size of plasma NO stores...

Descripción completa

Detalles Bibliográficos
Autores principales: Reinero, Melanie, Beghetti, Maurice, Tozzi, Piergiorgio, von Segesser, Ludwig K., Samaja, Michele, Milano, Giuseppina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Experimental Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547238/
https://www.ncbi.nlm.nih.gov/pubmed/33969747
http://dx.doi.org/10.1177/10742484211014162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547238/
https://www.ncbi.nlm.nih.gov/pubmed/33969747
http://dx.doi.org/10.1177/10742484211014162

Ejemplares similares